Average Co-Inventor Count = 10.63
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (9 from 125 patents)
2. Valo Health, Inc. (5 from 31 patents)
3. Valo Early Discovery, Inc. (2 from 15 patents)
4. H. Lee Moffitt Cancer Center and Research Institute, Inc. (1 from 293 patents)
15 patents:
1. 12479807 - METHODS USING HDAC11 INHIBITORS
2. 11919839 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
3. 11414392 - [6,6] fused bicyclic HDAC8 inhibitors
4. 11345672 - Methods using HDAC11 inhibitors
5. 10988441 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
6. 10829460 - [6,6] fused bicyclic HDAC8 inhibitors
7. 10538496 - Methods using HDAC11 inhibitors
8. 10508077 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
9. 10508088 - Methods using HDAC11 inhibitors
10. 10370343 - [6,6] Fused bicyclic HDAC8 inhibitors
11. 10266487 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
12. 10029995 - [6,6] fused bicyclic HDAC8 inhibitors
13. 9745253 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
14. 9637453 - 3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors
15. 9630922 - 3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors